Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Facial feminization surgery helps make facial features more feminine, improving patient satisfaction and safety.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Australia needs better dermatological guidelines for gender-diverse patients.

Few dermatology programs mention gender-affirming care, highlighting a need for better training and visibility.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hair growth can be influenced by manipulating keratin and growth factor genes.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

There is unequal access to gender-affirming surgeries in Canada, with a need for better coverage and specialized programs.

The conclusion is that certain surgeries can help people with gender dysphoria look more like their true gender and feel better.

Facial Feminization Surgery is effective and safe, with minimal complications.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

DNMT3A is crucial for healthy skin and hair growth.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Dutasteride effectively treats hair loss and prostate issues.

The document summarized various dermatology studies and case reports.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Human hair follicle cells can grow hair when put into mouse skin if they stay in contact with mouse cells.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Transgender patients face more barriers to oral healthcare, leading to poorer oral health and quality of life.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.